These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 7816151)
21. Clinicians' experiences in combining medication and psychotherapy in the treatment of borderline patients. Waldinger RJ; Frank AF Hosp Community Psychiatry; 1989 Jul; 40(7):712-8. PubMed ID: 2777227 [TBL] [Abstract][Full Text] [Related]
22. Quality of life in borderline personality disorder. IsHak WW; Elbau I; Ismail A; Delaloye S; Ha K; Bolotaulo NI; Nashawati R; Cassmassi B; Wang C Harv Rev Psychiatry; 2013; 21(3):138-50. PubMed ID: 23660969 [TBL] [Abstract][Full Text] [Related]
23. [Possibilities in psychiatric-psychotherapeutic and family practice treatment of borderline patients]. Flury HP Praxis (Bern 1994); 1995 May; 84(21):633-9. PubMed ID: 7784765 [TBL] [Abstract][Full Text] [Related]
24. Integrative Treatment of Personality Disorder. Part I: Psychotherapy. Jovanovic MD; Svrakic D Psychiatr Danub; 2017 Mar; 29(1):2-13. PubMed ID: 28291968 [TBL] [Abstract][Full Text] [Related]
25. Borderline personality disorder and bipolar disorder comorbidity in suicidal patients: diagnostic and therapeutic challenges. Marcinko D; Vuksan-Cusa B Psychiatr Danub; 2009 Sep; 21(3):386-90. PubMed ID: 19794362 [TBL] [Abstract][Full Text] [Related]
26. [The value of psychopharmacotherapy in the treatment of borderline personality disorder]. Leitner P; Serfling R Psychiatr Prax; 1993 Nov; 20(6):207-10. PubMed ID: 7906044 [TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapy of patients with borderline personality disorder. Teicher MH; Glod CA Hosp Community Psychiatry; 1989 Sep; 40(9):887-9. PubMed ID: 2676822 [No Abstract] [Full Text] [Related]
28. Progress in the treatment of borderline personality disorder. Livesley WJ Can J Psychiatry; 2005 Jul; 50(8):433-4. PubMed ID: 16127959 [No Abstract] [Full Text] [Related]
29. Evidence for the treatment of borderline personality disorder. Gagliardi JP; Krishnan RR Psychopharmacol Bull; 2003; 37(1):30-46. PubMed ID: 14561947 [TBL] [Abstract][Full Text] [Related]
34. The evidence that supports the effectiveness of certain psychopharmacologic agents and concern over the appropriate use of others. Flach F Essent Psychopharmacol; 2005; 6(6):vii-viii. PubMed ID: 16459753 [No Abstract] [Full Text] [Related]
35. [Drug therapy of patients with emotionally unstable personality]. Nissen T Tidsskr Nor Laegeforen; 2000 Aug; 120(18):2135-41. PubMed ID: 11006733 [TBL] [Abstract][Full Text] [Related]
36. [Psychotherapeutic effects of psychotropic drugs: principle considerations from the psychobiologic viewpoint]. Langer G Wien Med Wochenschr; 1986 Oct; 136(19-20):491-7. PubMed ID: 3027996 [TBL] [Abstract][Full Text] [Related]
37. [Limited indications for chemotherapy in the management of "borderline"]. Barbier D Soins Psychiatr; 1991; (130-131):51-2. PubMed ID: 1824469 [No Abstract] [Full Text] [Related]
39. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Giesen-Bloo J; van Dyck R; Spinhoven P; van Tilburg W; Dirksen C; van Asselt T; Kremers I; Nadort M; Arntz A Arch Gen Psychiatry; 2006 Jun; 63(6):649-58. PubMed ID: 16754838 [TBL] [Abstract][Full Text] [Related]
40. Recognizing and treating uncommon behavioral and emotional disorders in children and adolescents who have been severely maltreated: borderline personality disorder. Haugaard JJ Child Maltreat; 2004 May; 9(2):139-45. PubMed ID: 15104882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]